The Worldwide Innovative Network (WIN) Consortium in personalized cancer medicine is proud to announce that AstraZeneca, DKFZ and EORTC have joined the Consortium.

See original article:
DKFZ, AstraZeneca EORTC join Worldwide Innovative Network Consortium